(Q54189352)

26 May 2018

title

The angiotensin-(1-7)/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice. (English)

1 reference

26 May 2018

author

Enrique Brandan

5

1 reference

26 May 2018

Johanna Abrigo

object named as

Johanna Abrigo

3

0 references

author name string

Carla Meneses

1

1 reference

26 May 2018

María Gabriela Morales

2

1 reference

26 May 2018

Felipe Simon

4

1 reference

26 May 2018

Claudio Cabello-Verrugio

6

1 reference

26 May 2018

publication date

9 October 2014

1 reference

26 May 2018

published in

Pfluegers Archiv

1 reference

26 May 2018

volume

467

1 reference

26 May 2018

issue

9

1 reference

26 May 2018

page(s)

1975-1984

1 reference

26 May 2018

Restoration of muscle strength in dystrophic muscle by angiotensin-1-7 through inhibition of TGF-β signalling

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Identification of ubiquitin ligases required for skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Cellular and molecular mechanisms of muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin II and Cardiac Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin II: role in skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin II as candidate of cardiac cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

The role of apoptosis in age-related skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Increased expression of phosphorylated forms of RNA-dependent protein kinase and eukaryotic initiation factor 2alpha may signal skeletal muscle atrophy in weight-losing cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Molecular mechanisms modulating muscle mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Signaling pathways perturbing muscle mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Atrogin-1, MuRF-1, and sarcopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

β-Hydroxy-β-methylbutyrate reduces myonuclear apoptosis during recovery from hind limb suspension-induced muscle fiber atrophy in aged rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin-(1-7) modulates renin-angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Impact of angiotensin II on skeletal muscle metabolism and function in mice: contribution of IGF-1, Sirtuin-1 and PGC-1α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Myostatin promotes the wasting of human myoblast cultures through promoting ubiquitin-proteasome pathway-mediated loss of sarcomeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty - a mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Modulation of age-induced apoptotic signaling and cellular remodeling by exercise and calorie restriction in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

CTGF/CCN-2 over-expression can directly induce features of skeletal muscle dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Transforming growth factor type beta 1 increases the expression of angiotensin II receptor type 2 by a SMAD- and p38 MAPK-dependent mechanism in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Oxidative stress and disuse muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Mechanism of induction of muscle protein degradation by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Chronic oral administration of Ang-(1-7) improves skeletal muscle, autonomic and locomotor phenotypes in muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Signaling in muscle atrophy and hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Mechanisms regulating skeletal muscle growth and atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin II induced catabolic effect and muscle atrophy are redox dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Apoptotic responses to hindlimb suspension in gastrocnemius muscles from young adult and aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin II, oxidative stress and skeletal muscle wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

WITHIN-PATIENT VARIABILITY OF HORMONE AND CYTOKINE CONCENTRATIONS IN HEART FAILURE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00424-014-1617-9

Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure

21 January 2018

1 reference

12 December 2020

Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysis-inducing factor and angiotensin II

1 reference

12 December 2020

Myofiber apoptosis occurs in the inflammation and regeneration phase following eccentric contractions in rats

1 reference

12 December 2020

Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation

1 reference

12 December 2020

The Ang-(1-7)/Mas-1 axis attenuates the expression and signalling of TGF-β1 induced by AngII in mouse skeletal muscle.

1 reference

12 December 2020

Multiple pathways to the same end: mechanisms of myonuclear apoptosis in sarcopenia of aging

1 reference

12 December 2020

Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats

1 reference

12 December 2020

Mitochondria-associated apoptotic signalling in denervated rat skeletal muscle

1 reference

12 December 2020

Skeletal muscle activity and the fate of myonuclei.

1 reference

12 December 2020

Apoptosis in heart and skeletal muscle.

1 reference

12 December 2020

Effect of denervation on mitochondrially mediated apoptosis in skeletal muscle

1 reference

12 December 2020

Effects of short-term GH supplementation and treadmill exercise training on physical performance and skeletal muscle apoptosis in old rats

1 reference

12 December 2020

The Mas receptor mediates modulation of insulin signaling by angiotensin-(1-7)

1 reference

12 December 2020

Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig-Hoffmann disease

1 reference

12 December 2020

Targeting the angiotensin pathway in idiopathic pulmonary fibrosis

1 reference

12 December 2020

Role of the kallikrein-kinin system in Ang-(1-7)-induced vasodilation in mesenteric arterioles of Wistar rats studied in vivo-in situ

1 reference

12 December 2020

Suicide muscle cell programme-apoptosis. Ultrastructural study

1 reference

12 December 2020

The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle

1 reference

12 December 2020

Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure

1 reference

12 December 2020

Angiotensin II type 1 receptor blocker inhibits pulmonary injury.

1 reference

12 December 2020

Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I

1 reference

12 December 2020

Fibrotic response induced by angiotensin-II requires NAD(P)H oxidase-induced reactive oxygen species (ROS) in skeletal muscle cells

1 reference

12 December 2020

Angiotensin-(1-7)/angiotensin-converting enzyme 2/mas receptor axis and related mechanisms.

1 reference

12 December 2020

Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting.

1 reference

12 December 2020

10.1007/S00424-014-1617-9

Identifiers

DOI

1 reference

26 May 2018

1 reference

26 May 2018